Our director Andrew Lloyd and senior research manager Katy Gallop recently co-authored the paper “Estimation of the quality of life benefits associated with treatment for spinal muscular atrophy” in ClinicoEconomics and Outcomes Research. The full text is available here.
New Acaster Lloyd Consulting publication
Our director Andrew Lloyd and research associate Natalia Piglowska recently co-authored a paper entitled ‘Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy’ in the British Journal of Ophthalmology.
Acaster Lloyd Consulting presentation at the Society for Medical Decision Making
We are pleased to announce that our director Andrew Lloyd was co-author on a poster entitled ‘Can the EQ-5D capture health outcomes in degenerative rare diseases? An international study’ which received the Lee B Lusted award for Patient and Stakeholder Preferences at the Society for Medical Decision Making last week. Please contact us if you would like a copy of the poster.
New publication by Sarah Acaster
This new paper by our Director, Sarah Acaster, reports on a novel biomarker in celiac disease, which unlike existing biomarkers used in this disease area is correlated with patient reported symptoms, and demonstrates the nature and time course of symptom change in the hours following gluten ingestion.
Andrew Lloyd co-authors paper on data visualisation techniques in HEOR
A new paper from Andrew Lloyd discusses the opportunities and challenges associated with data visualisation techniques in health economics and outcomes research (HEOR)
Acaster Lloyd Consulting poster presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Our director Andrew Lloyd and research associate Natalia Piglowska were both part of the study team to develop health-related quality of life weights (utilities) for health states describing different levels of vision loss in individuals with RPE65-Mediated Inherited Retinal Disorder (IRD). If you’re going to ARVO next week, you can view their poster ‘Estimation of Impact of RPE65-Mediated Inherited Retinal Disease on Quality of Life’ in the ‘Patient perspectives and reported outcomes’ session on Wednesday 1st May.
Andrew Lloyd part of a team to publish new ISPOR Good Practices for Outcomes Research Task Force Report
New paper in Value in Health on the identification, review, and use of health state utilities in cost-effectiveness models.
